Allergan, Inc., a global pharmaceutical company focused on developing, manufacturing, and commercializing branded pharmaceutical, is being sued by women across America for the use of its BIOCELL implants, which has allegedly been linked to a serious form of lymphoma.
Allergan, Inc. announced a worldwide recall of BIOCELL after the U.S. Food & Drug Administration (FDA) called for the action following new information that its implants were tied to a vast majority of these types of cancer cases. The lymphoma is known as BIA-ALCL, an implant-associated anaplastic large cell lymphoma (i.e. a type of non-Hodgkin’s lymphoma).
In most cases, BIA-ALCL is found in the scar tissue and fluid near the implant. However, in some cases, this can spread throughout the body.
While an individual’s risk of developing BIA-ALCL is considered low, this cancer is serious and can lead to death, especially if treatment isn’t sought immediately. In addition, the procedure to diagnose BIA-ALCL is invasive.
Moreover, the FDA stated that the risk of developing this type of lymphoma is about six times higher if an Allergan BIOCELL implant was used. Within the span of several months—from early 2019 to July 2019—reports have skyrocketed, with 116 new cases and 24 more deaths of patients using BIOCELL implants.
As leading Florida medical malpractice attorneys, Grossman Roth Yaffa Cohen cares for your safety. If you have received a breast augmentation using BIOCELL implants, we urge you to consult your doctor immediately and consider removing them. If you have been affected by the implant and are in need of representation, our firm can help.
Please fill out a case review form at the bottom of this page if you believe you qualify to join our class-action lawsuit against Allergan, Inc.
Grossman Roth Yaffa Cohen has over 30 years of experience in medical malpractice and class-action lawsuits. For more information, please view our medical malpractice outcomes here.
